Comparison of 3D Structures and AT1 Binding Properties of Pyrazolidine-3,5-diones and Tetrahydropyridazine-3,6-diones with Parent Antihypertensive Drug Irbesartan
- 12 September 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (21) , 4794-4798
Abstract
A new series of nonpeptide AT1 receptor antagonists were recently developed, based on the structure of irbesartan (Le Bourdonnec et al. J. Med. Chem. 2000, 43, 2685−2697). The lead compound 1 displayed high selectivity for the AT1 receptor subtype but lower binding affinity than irbesartan. As expected from molecular modeling studies, extension of the pyrazolidine-3,5-dione scaffold to the six-membered heterocycle tetrahydropyridazine-3,6-dione led to an enhancement of the binding affinity toward the AT1 receptor.Keywords
This publication has 9 references indexed in Scilit:
- A new synthesis ofN-alkyl pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-dionesJournal of Heterocyclic Chemistry, 2000
- IrbesartanDrugs, 1997
- Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive TherapyJournal of Medicinal Chemistry, 1996
- Bond lengths, and beyondActa crystallographica Section B, Structural science, crystal engineering and materials, 1995
- Pyrido[2,3-d]pyrimidine Angiotensin II AntagonistsJournal of Medicinal Chemistry, 1994
- A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonistsJournal of Medicinal Chemistry, 1993
- A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonistsJournal of Computer-Aided Molecular Design, 1993
- Part VI. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensivesJournal of Medicinal Chemistry, 1990
- The Renin-Angiotensin SystemJournal of Cardiovascular Pharmacology, 1990